Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin

Fatemeh Alikarami‬(Iran University of Medical Sciences), Ahmad Kazemi(Iran University of Medical Sciences), Majid Safa(Iran University of Medical Sciences), Mohammad Faranoush(Iran University of Medical Sciences), Parisa Hayat(Iran University of Medical Sciences)
Biomedicine & Pharmacotherapy
August 16, 2017
10.1016/j.biopha.2017.08.022
Cited by 31

Related Papers

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in <i>KMT2A</i>-rearranged leukemia
|Blood|2021|113
MITI minimum information guidelines for highly multiplexed tissue images
|Nature Methods|2022|86
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
|Biomarker Research|2023|48
Overexpression of Orphan Receptor Tyrosine Kinase &lt;i&gt;Ror1&lt;/i&gt; as a Putative Tumor-Associated Antigen in Iranian Patients with Acute Lymphoblastic Leukemia
|Tumor Biology|2007|46